Price:
Rs. 120,000.00
Sample Type: Tissue
Fasting Not Required
Notes:N8220
Frequently Asked Questions (FAQ's):
What does the GeneCore Paradigm – PD-L1 and HRD Panel at Metropolis Healthcare include?
It measures PD-L1 expression through IHC and evaluates HRD status using advanced genomic analysis.
How does Metropolis Healthcare perform PD-L1 and HRD testing?
Metropolis Healthcare uses validated PD-L1 immunohistochemistry and high-quality genomic workflows to assess HRD markers.
Who should consider taking this test at Metropolis Healthcare?
Patients with solid tumors who need evaluation for immunotherapy or PARP inhibitor suitability should consider this panel.
Is fasting required for this test at Metropolis Healthcare?
No fasting is needed; testing is performed on tumor tissue samples provided by the clinician.
How long do results take at Metropolis Healthcare?
Results typically take 2–3 weeks due to the combined genomic and IHC analysis.
Can this panel at Metropolis Healthcare help guide immunotherapy decisions?
Yes, PD-L1 expression helps determine potential response to immune checkpoint inhibitors.
Can HRD testing at Metropolis Healthcare guide targeted therapy?
Yes, HRD results support the selection of PARP inhibitors and related targeted treatments.
How accurate are the PD-L1 and HRD assessments at Metropolis Healthcare?
Metropolis Healthcare ensures high accuracy through validated testing platforms and strict quality protocols.